Patent directory · USPTO A61K / A61P
Patents matching “antagonist”
678 pharma patents match "antagonist" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 678 pharmaceutical patents matching "antagonist" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11111272
α4α7 peptide monomer and dimer antagonists
granted -
US 11104730
Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors
granted -
US 11084865
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 11078201
Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists
granted -
US 11077108
Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition
granted -
US 11066458
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 11034768
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted -
US 11034694
Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists
granted -
US 11033539
Compounds of formulas (VII), (VIII), (IX), (XI), (XII), (XIII), and (XIV) as muscarinic receptor 4(M4) antagonists for treating neurological diseases
granted -
US 11033554
Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration
granted -
US 11026997
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11026920
Use of NK-1 receptor antagonist serlopitant in pruritus
granted -
US 11028085
Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists
granted -
US 11021481
Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists
granted -
US 11007201
Corticotropin releasing factor receptor antagonists
granted -
US 10981894
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
granted -
US 10973879
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
CA 3156009
POLYTHERAPIE AVEC DES ANTAGONISTES DU CGRP
granted -
WO 2021058549
ANTAGONISTE GRPR RADIOMARQUÉ POUR L'UTILISATION COMME AGENT THÉRAGNOSTIQUE
granted -
WO 2021053040
MÉTHODES DE RADIOMARQUAGE D'ANTAGONISTES DE GRPR ET LEURS KITS
granted -
US 10947206
cGAS antagonist compounds
granted -
US 10946009
Combination dosage form of a mu opioid receptor antagonist and an opioid agent
granted -
US 10941159
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
granted -
US 10905769
Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
granted